68 related articles for article (PubMed ID: 12002910)
1. Serum concentrations of lipids and apolipoprotein E in angiographically defined coronary artery disease patients.
Leowattana W; Pokum S; Mahanonda N; Jiumbunjong N
J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S684-9. PubMed ID: 12002910
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
Sharma R; Mahajan M; Singh B; Bal BS; Kant R
J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
[TBL] [Abstract][Full Text] [Related]
3. Gender-related effect of apo E polymorphism on lipoprotein particle sizes in the middle-aged subjects.
Topic A; Spasojevic Kalimanovska V; Zeljkovic A; Vekic J; Jelic Ivanovic Z
Clin Biochem; 2008 Apr; 41(6):361-7. PubMed ID: 18086568
[TBL] [Abstract][Full Text] [Related]
4. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
5. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
7. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease.
Serdar Z; Yeşilbursa D; Dirican M; Sarandöl E; Serdar A
Cell Biochem Funct; 2007; 25(6):655-64. PubMed ID: 17006879
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations of the apolipoprotein B gene in Turkish patients with coronary artery disease.
Duman BS; Türkoğlu C; Akpinar B; Güden M; Vertii A; Cağatay P; Günay D; Sevim Büyükdevrim A
Ann Hum Biol; 2005; 32(5):620-9. PubMed ID: 16316917
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein associated with coronary artery disease in Iranian patients with angiographically defined coronary artery disease.
Kazemi-Bajestani SM; Ghayour-Mobarhan M; Ebrahimi M; Moohebati M; Esmaeili HA; Ferns GA
Clin Lab; 2007; 53(1-2):49-56. PubMed ID: 17323825
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E gene polymorphism in renal transplant recipients: effects on lipid metabolism, atherosclerosis and allograft function.
Kahraman S; Kiykim AA; Altun B; Gençtoy G; Arici M; Gulsun M; Erdem Y; Yasavul U; Turgan C; Cağlar S
Clin Transplant; 2004 Jun; 18(3):288-94. PubMed ID: 15142050
[TBL] [Abstract][Full Text] [Related]
11. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E polymorphism and carotid atherosclerosis in patients with coronary disease.
Fernández-Miranda C; Aranda JL; Martín MA; Arenas J; Núñez V; Gómez de la Cámara A
Int J Cardiol; 2004 Apr; 94(2-3):209-12. PubMed ID: 15093983
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
Barbagallo CM; Rizzo M; Noto D; Frasheri A; Pernice V; Rubino A; Pieri D; Pinto V; Cefalù AB; Giordano C; Notarbartolo A; Averna MR
Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
[TBL] [Abstract][Full Text] [Related]
14. Is increased apolipoprotein B-A major factor enhancing the risk of coronary artery disease in type 2 diabetes?
Snehalatha C; Ramachandran A; Sivasankari S; Satyavani K; Viswanathan V; Misra J; Girinath MR; Sathyamurthy I
J Assoc Physicians India; 2002 Aug; 50():1036-8. PubMed ID: 12421026
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein e4 allele and the risk of CAD death in type 2 diabetes mellitus with ischaemia electrocardiographic change.
Guang-da X; Xiang-Jiu Y; Lin-Shuang Z; Zhi-Song C; Yu-Sheng H
Diabetes Res Clin Pract; 2005 Jun; 68(3):223-9. PubMed ID: 15936464
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism, age and coronary heart disease.
Kolovou GD; Anagnostopoulou KK
Ageing Res Rev; 2007 Aug; 6(2):94-108. PubMed ID: 17224309
[TBL] [Abstract][Full Text] [Related]
17. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
Rump P; Mensink RP; Hornstra G
Nutr Metab Cardiovasc Dis; 2002 Dec; 12(6):317-24. PubMed ID: 12669678
[TBL] [Abstract][Full Text] [Related]
18. Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases.
Tirawanchai N; Leowattana W; Somkasetrin A; Thongsaen P
J Med Assoc Thai; 2008 Jan; 91(1):86-92. PubMed ID: 18386550
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosis.
Gelman BB; Rifai N; Christenson RH; Silverman LM
Ann Clin Lab Sci; 1988; 18(1):46-52. PubMed ID: 3355096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
